Novel voltage-dependent cation channel protein
CA 2446708 A1 · Owner: Takahashi, Tomohiro · Inventors: Okawa, Kazufumi; Takahashi, Tomohiro; Nakamura, Yusuke
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
It is intended to provide a gene and a protein participating in central nerve diseases and a method of efficiently evaluating an activity controller for the protein. A DNA comprising the base sequence represented by SEQ ID NO:1; a potential-dependent cation channel protein encoded by the DNA; an antisense nucleic acid against the DNA sequence; a method of searching for a substance controlling the channel function of the above protein with the use of the protein; and antibodies specific to the antisense nucleic acid to the DNA and the protein.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 10, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 10, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 10, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.